Coeptis Therapeutics
COEP
COEP
21 hedge funds and large institutions have $1.41M invested in Coeptis Therapeutics in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
62% less capital invested
Capital invested by funds: $3.71M → $1.41M (-$2.3M)
Holders
21
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$133K | |
| 2 | +$14.1K | |
| 3 | +$5.32K | |
| 4 |
AA
ACT Advisors
Asheville,
North Carolina
|
+$3.11K |
| 5 |
HF
HRT Financial
New York
|
+$3K |
Top Sellers
| 1 | -$146K | |
| 2 | -$17.8K | |
| 3 | -$9.47K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$8.54K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$761 |